Catalyst Pharmaceutical Partners shares owned by AQR Capital Management
Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by AQR Capital Management
from 13F filings
Historical chart of AQR Capital Management investment in Catalyst Pharmaceutical Partners
Tip: Access up to 7 years of quarterly data
All positions including Catalyst Pharmaceutical Partners held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Catalyst Pharmaceutical Partners by AQR Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $4.2M | 261k | 15.93 |
| 2023-12-31 | $5.8M | 343k | 16.81 |
| 2023-09-30 | $5.6M | 477k | 11.69 |
| 2023-06-30 | $8.6M | 643k | 13.44 |
| 2023-03-31 | $4.4M | 264k | 16.58 |
| 2022-12-31 | $4.2M | 228k | 18.60 |
| 2022-09-30 | $5.1M | 401k | 12.83 |
| 2022-06-30 | $3.4M | 488k | 7.01 |
| 2022-03-31 | $3.4M | 414k | 8.29 |
| 2021-12-31 | $3.0M | 438k | 6.77 |
| 2021-09-30 | $2.5M | 475k | 5.30 |
| 2021-06-30 | $1.9M | 324k | 5.75 |
| 2021-03-31 | $3.3M | 724k | 4.61 |
| 2020-12-31 | $3.3M | 993k | 3.34 |
| 2020-09-30 | $2.5M | 850k | 2.97 |
| 2020-06-30 | $4.2M | 905k | 4.62 |
| 2020-03-31 | $4.7M | 1.2M | 3.85 |
| 2019-12-31 | $4.3M | 1.1M | 3.75 |
| 2019-09-30 | $885k | 167k | 5.31 |
| 2019-06-30 | $1.1M | 280k | 3.84 |
| 2019-03-31 | $319k | 63k | 5.10 |
| 2018-12-31 | $269k | 140k | 1.92 |
| 2018-09-30 | $751k | 199k | 3.78 |
| 2018-06-30 | $1.2M | 375k | 3.12 |
| 2018-03-31 | $1.9M | 803k | 2.39 |
| 2017-12-31 | $1.3M | 337k | 3.91 |
| 2017-09-30 | $889k | 353k | 2.52 |
| 2015-12-31 | $156k | 64k | 2.45 |
| 2015-09-30 | $419k | 140k | 3.00 |
| 2015-06-30 | $763k | 185k | 4.13 |
| 2015-03-31 | $800k | 185k | 4.33 |
| 2014-12-31 | $626k | 211k | 2.97 |
| 2014-09-30 | $798k | 240k | 3.32 |
| 2014-06-30 | $608k | 240k | 2.53 |
| 2014-03-31 | $455k | 201k | 2.26 |
| 2013-12-31 | $292k | 150k | 1.95 |
Top funds holding Catalyst Pharmaceutical Partners
View all funds holding Catalyst Pharmaceutical Partners